| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 439.61B | 436.11B | 410.53B | 425.17B | 381.43B | 349.24B |
| Gross Profit | 42.11B | 41.88B | 40.88B | 38.57B | 35.45B | 34.36B |
| EBITDA | 22.08B | 21.67B | 14.65B | 13.83B | 11.71B | 11.39B |
| Net Income | 12.31B | 12.20B | 7.51B | 7.48B | 5.98B | 6.92B |
Balance Sheet | ||||||
| Total Assets | 178.47B | 171.92B | 161.18B | 146.52B | 142.43B | 131.73B |
| Cash, Cash Equivalents and Short-Term Investments | 18.20B | 16.29B | 17.02B | 11.10B | 11.17B | 14.75B |
| Total Debt | 46.33B | 42.56B | 39.99B | 40.28B | 42.10B | 42.03B |
| Total Liabilities | 91.34B | 83.17B | 83.18B | 76.34B | 78.42B | 72.60B |
| Stockholders Equity | 87.13B | 88.74B | 78.00B | 70.41B | 64.18B | 59.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.85B | 6.70B | 3.93B | -1.61B | 7.65B |
| Operating Cash Flow | 0.00 | -2.26B | 12.78B | 7.21B | 1.42B | 11.08B |
| Investing Cash Flow | 0.00 | 613.00M | -4.85B | -4.19B | -3.45B | -3.44B |
| Financing Cash Flow | 0.00 | 811.00M | -2.10B | -3.17B | -1.59B | -2.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥45.92B | 3.60 | ― | 2.55% | 8.21% | 20.27% | |
69 Neutral | ¥190.20B | 3.30 | 12.56% | 3.44% | 3.80% | 63.03% | |
69 Neutral | ¥22.98B | 2.45 | ― | 2.54% | 2.80% | 154.89% | |
67 Neutral | ¥65.98B | 20.57 | ― | 3.77% | -3.91% | -25.32% | |
66 Neutral | ¥74.09B | 5.03 | ― | 2.92% | 5.18% | 90.21% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥309.64B | 10.01 | ― | 1.45% | 20.02% | ― |